Search In this Thesis
   Search In this Thesis  
العنوان
New Oral Antiـcoagulants In Management Of Deep Venous Thrombosis/
المؤلف
Khalil,Mahmoud Ezzat Mohamed
هيئة الاعداد
باحث / محمود عزت محمد خليل
مشرف / عمرو أحمد عبد العال
مشرف / عبد الرحمن محمد أحمد
مشرف / محمد محمود زكى
تاريخ النشر
2016.
عدد الصفحات
152.p;
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
جراحة
تاريخ الإجازة
1/10/2016
مكان الإجازة
جامعة عين شمس - كلية الطب - General Surgery
الفهرس
Only 14 pages are availabe for public view

from 153

from 153

Abstract

The ideal revascularization strategy remains controversial and depends on the anatomic complexity of the lesions that require revascularization, the comorbidities, and the ability to use dual antiplatelet therapy. Through coronary artery by-pass grafting (CABG) is considered the gold standard of the revascularization approaches, the development of newer-generation coronary stents and safer medications have challenged this status. The major advantage of CABG over percutaneous coronary intervention (PCI) remains the use of the left internal mammary artery (LIMA) to bypass the left anterior descending (LAD). Angina pectoris (AP) represents the clinical syndrome occurring when myocardial oxygen demand exceeds supply. More serious cases of coronary artery disease require coronary artery bypass graft surgery (CABG), a procedure designed to restore blood flow to the myocardium. Performed since the late 1960s, this is now one of the most common operations in the United States-up to 500,000 are done yearly. The publications suggested that HCR is feasible, safe and effective for treatment of MCAD, with similar in-hospital and one-year follow-up outcomes, significantly lower requirement for RBC transfusion, and faster recovery compared with CABG. It may provide a safe and effective alternative for treating selected patients with MCAD.